Hormonal Control and Second Messengers

Spec mapping: AQA 7402 Section 3.6.4 — hormonal coordination of physiological responses, including steroid vs peptide hormone mechanisms, second-messenger cascades (cyclic AMP), target-tissue specificity, and the amplification afforded by enzymatic cascades (refer to the official AQA specification document for exact wording).

Hormonal control is the second of the two great signalling architectures of multicellular animals — partnering with nervous control to coordinate physiology across time, distance and organisational scale. Where the nervous system delivers fast, point-to-point, electrically encoded signals (Course 6), hormones deliver slower, broadcast, chemically encoded signals that propagate to every cell expressing the relevant receptor. The combination is not redundant. Many responses (the fight-or-flight reaction, post-prandial glucose handling, the menstrual cycle) require both: rapid neural mobilisation followed by sustained hormonal modulation, or vice versa. This lesson develops the molecular machinery that converts a hormone molecule arriving at a target tissue into a physiological response — a process that distinguishes two great classes of hormone (steroid versus peptide), invokes amplification cascades that turn single hormone molecules into millions of downstream effects, and provides the integrating logic that ties the previous lessons in this course together.

Key Definition: A hormone is a chemical messenger secreted directly into the bloodstream by an endocrine gland or specialised cell, transported in plasma, and acting on distant target cells that express specific receptors. A second messenger is an intracellular signalling molecule generated in response to receptor activation, transmitting and amplifying the signal to downstream effectors within the cell.

---

Nervous vs Hormonal Signalling — Architectural Comparison

Feature	Nervous signalling	Hormonal signalling
Medium	Action potentials along axons; neurotransmitters at synapses	Hormones in blood plasma
Speed	Milliseconds	Seconds (peptide) to hours (steroid); chronic effects over days
Range	Point-to-point (synaptic) or short-range (paracrine)	Broadcast — every cell exposed; specificity via receptor expression
Duration	Brief, terminated by reuptake or breakdown of neurotransmitter	Sustained — terminated by hormone clearance and feedback
Encoding	Frequency and pattern of action potentials	Plasma concentration of hormone
Energy cost	High (continuous ion-pump activity)	Lower per signal but sustained
Specificity	Anatomical (which axon, which synapse)	Molecular (which receptor on which tissue)
Best for	Rapid reflexes, fine motor control, fast sensory feedback	Long-term coordination, growth, reproduction, metabolism

The two systems are deeply integrated. The hypothalamus is the cardinal interface: hypothalamic neurones receive synaptic input from the rest of the brain and secrete releasing hormones that modulate the anterior pituitary, which in turn secretes trophic hormones that drive distant endocrine glands (thyroid, adrenal cortex, gonads). The adrenal medulla is itself anatomically a sympathetic ganglion — its cells are modified postganglionic neurones that release adrenaline into blood rather than onto synaptic targets, illustrating that the nervous–endocrine boundary is biologically blurred.

---

Two Classes of Hormone

A practical first division of hormones is by chemistry, because the chemistry dictates the mechanism.

Lipid-soluble hormones (steroid and thyroid)

• Examples: oestrogen, progesterone, testosterone, cortisol, aldosterone, vitamin D (technically a hormone), thyroxine.
• Source: synthesised from cholesterol (steroids) or from tyrosine + iodine (thyroxine).
• Transport: bound to plasma carrier proteins (sex-hormone-binding globulin, cortisol-binding globulin, thyroxine-binding globulin) — only the free hormone is biologically active.
• Membrane crossing: diffuse directly across plasma membranes (lipid-soluble; small).
• Receptor location: cytoplasmic or nuclear; intracellular.
• Mechanism: hormone–receptor complex binds DNA (hormone response elements) and modulates gene transcription. The receptor is itself a transcription factor (synoptic with Course 10, lesson 0 — gene expression).
• Time course: slow onset (~hours to days, because transcription, translation and protein turnover are required) and prolonged action.
• Reversibility: terminated by hormone clearance, receptor downregulation, and decay of the synthesised proteins.

Water-soluble hormones (peptide, protein, catecholamine)

• Examples: insulin, glucagon, growth hormone, prolactin, ADH, FSH, LH, oxytocin, adrenaline (a catecholamine, mechanistically similar).
• Source: synthesised on rough endoplasmic reticulum as pre-pro-hormones, processed in Golgi, packaged into secretory vesicles.
• Transport: free in plasma (no carrier proteins; relatively short plasma half-life — typically minutes).
• Membrane crossing: cannot cross the lipid bilayer (water-soluble; large).
• Receptor location: cell-surface membrane proteins.
• Mechanism: hormone binding to extracellular receptor domain triggers an intracellular signal cascade via second messengers — cyclic AMP, IP₃/diacylglycerol, Ca²⁺, or tyrosine-kinase autophosphorylation.
• Time course: rapid onset (~seconds to minutes) and shorter duration.
• Reversibility: rapid, by receptor desensitisation, second-messenger degradation, and hormone clearance.

The chemistry dictates the mechanism: lipid solubility determines whether the receptor must be intracellular (steroid, slow, transcriptional) or extracellular (peptide, fast, signal-cascade).

---

Steroid Hormone Mechanism

Take oestradiol (an oestrogen) as the model.

1. Synthesis and secretion: granulosa and theca cells of the ovary synthesise oestradiol from cholesterol via the aromatase pathway. Secretion is pulsatile and follows the menstrual cycle (lesson 5).
2. Plasma transport: oestradiol binds sex-hormone-binding globulin (SHBG) for transport; ~2% remains free.
3. Membrane crossing: free oestradiol diffuses across the target cell plasma membrane unimpeded — its lipid solubility makes the bilayer no barrier.
4. Receptor binding: cytoplasmic or nuclear oestrogen receptor (ERα or ERβ) binds oestradiol. The ligand-bound receptor undergoes conformational change, releases inhibitory heat-shock proteins, and dimerises.
5. DNA binding: the receptor dimer translocates to the nucleus (if not already there) and binds oestrogen response elements (EREs) — short palindromic DNA sequences in promoter regions of target genes.
6. Transcriptional modulation: bound receptor recruits co-activators (or co-repressors), modifying RNA polymerase II recruitment and gene transcription. Target genes encode proteins relevant to uterine growth, mammary development, calcium handling, and many other tissue-specific responses.
7. Translation and physiological response: target proteins are synthesised, fold, traffic and execute their function. The full response unfolds over hours to days.

A* candidates should appreciate that steroid hormones reprogramme the cell at the transcriptional level. The response is not a sudden change in existing protein activity (as for peptide-hormone cascades) but a remodelling of the cell's protein complement. This explains the slow onset and sustained duration.

flowchart LR
  Hormone[Hormone: H₂O-soluble<br/>e.g. glucagon] --> GPCR[G-protein-coupled receptor]
  GPCR --> Galpha[Gα-GTP activated]
  Galpha --> AC[Adenylyl cyclase activated]
  AC --> cAMP[ATP → cAMP]
  cAMP --> PKA[Protein kinase A activated]
  PKA --> Sub[Substrate proteins phosphorylated]
  Sub --> Resp[Physiological response<br/>e.g. glycogenolysis]

---

Peptide Hormone Mechanism — the cAMP Cascade in Detail

The cyclic-AMP second-messenger cascade is the archetype that the AQA specification expects candidates to know in molecular detail. The discovery framework was articulated by Earl Sutherland in the 1950s (paraphrased here — Sutherland received the 1971 Nobel Prize for the discovery that hormones act via an intracellular second messenger rather than directly on enzymes).

Take glucagon as the model (cross-reference lesson 2 on blood glucose).

1. Hormone arrives at the target cell: glucagon binds the glucagon receptor, a seven-transmembrane G-protein-coupled receptor (GPCR) on the hepatocyte surface.
2. Receptor activation: ligand binding induces a conformational change in the receptor's intracellular domain.
3. G-protein activation: the receptor catalyses exchange of GDP for GTP on the α-subunit of the associated heterotrimeric G-protein (Gαₛ in this case — the "s" denotes stimulatory). The activated Gαₛ-GTP dissociates from the βγ-subunits.
4. Adenylyl cyclase activation: Gαₛ-GTP binds and activates adenylyl cyclase, a membrane-bound enzyme.
5. Second-messenger generation: adenylyl cyclase converts cytoplasmic ATP into cyclic AMP (cAMP) by phosphodiester ring closure with elimination of pyrophosphate.
6. PKA activation: cAMP binds the regulatory subunits of protein kinase A (PKA), releasing the catalytic subunits which become enzymatically active.
7. Substrate phosphorylation: active PKA phosphorylates serine and threonine residues on dozens of substrate proteins. In hepatocytes, key targets include phosphorylase kinase (activates glycogen phosphorylase → glycogenolysis), glycogen synthase (inactivated, so glycogenesis is blocked), and the cAMP response-element-binding protein (CREB, which then modulates transcription of gluconeogenic genes).
8. Physiological response: glucose is liberated from glycogen and secreted into blood, raising plasma glucose.
9. Signal termination: Gαₛ-GTP intrinsically hydrolyses to Gαₛ-GDP (slow); cAMP is hydrolysed to AMP by phosphodiesterase; PKA-phosphorylated substrates are dephosphorylated by phosphatases; glucagon is cleared from plasma.

The architecture is elegant: a single GPCR can activate many G-proteins; each G-protein activates one adenylyl cyclase that produces many cAMP molecules; each PKA phosphorylates many substrates. The amplification factor through the cascade can exceed 10 000×: one glucagon molecule → ~100 G-proteins → ~10 000 cAMP → ~10⁵ phosphorylation events. This is why hormones are physiologically potent at picomolar plasma concentrations.

Other peptide-hormone mechanisms (briefly)

• Insulin uses a receptor tyrosine kinase (RTK) — insulin binding activates the receptor's intrinsic kinase activity, which autophosphorylates the receptor and phosphorylates insulin receptor substrate (IRS) proteins. Downstream cascades include the PI3K/Akt pathway driving GLUT4 translocation and glycogen synthase activation (lesson 2).
• ADH uses the V₂ vasopressin receptor, a Gαₛ-coupled GPCR signalling through the cAMP cascade — converging on aquaporin-2 insertion into collecting-duct apical membranes (lesson 1).
• Adrenaline acts on multiple α- and β-adrenoceptors with distinct G-protein couplings: β-adrenoceptors couple Gαₛ → cAMP (cardiac contractility, bronchodilation, glycogenolysis), α₁-adrenoceptors couple Gαq → IP₃/DAG/Ca²⁺ (smooth-muscle contraction, vasoconstriction), α₂-adrenoceptors couple Gαᵢ → adenylyl cyclase inhibition (presynaptic transmitter-release inhibition).

The same hormone (adrenaline) producing different responses in different tissues by binding different receptor subtypes coupled to different G-proteins is the molecular basis of tissue-specific drug responses — and the foundation of modern β-blocker pharmacology in cardiology.

The IP₃/DAG/Ca²⁺ Cascade

A second canonical second-messenger architecture, important for A-Level depth, operates via Gαq-coupled GPCRs.

1. Hormone (e.g., adrenaline binding α₁-adrenoceptors, ADH binding V₁ receptors, oxytocin binding its receptor) activates the receptor.
2. The receptor activates Gαq, which dissociates from βγ-subunits.
3. Gαq-GTP activates phospholipase C (PLC), a membrane enzyme that hydrolyses the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP₂) into two second messengers: inositol trisphosphate (IP₃) and diacylglycerol (DAG).
4. IP₃ diffuses to the smooth endoplasmic reticulum, binds IP₃ receptors (ligand-gated Ca²⁺ channels) and releases stored Ca²⁺ into the cytosol, raising free Ca²⁺ from ~100 nM at rest to ~1 μM during signalling.
5. DAG remains in the membrane and, together with Ca²⁺, activates protein kinase C (PKC), a serine/threonine kinase that phosphorylates substrate proteins.
6. Elevated cytosolic Ca²⁺ binds calmodulin, the universal Ca²⁺-sensor protein; the Ca²⁺/calmodulin complex activates calmodulin-dependent kinases (CaMKs) and myosin light-chain kinase (MLCK) in smooth muscle, driving contraction.

This cascade explains how the same hormone (e.g., adrenaline) drives smooth-muscle contraction in some tissues via Gαq/IP₃/Ca²⁺ and heart-rate increase in others via Gαₛ/cAMP. The architecture is fully parallel to the cAMP cascade but uses a different second-messenger language. Examiners reward candidates who recognise that "second messenger" is a general category encompassing cAMP, IP₃, DAG, Ca²⁺, cGMP, and others.

---

Quantitative Worked Example — Adrenaline Amplification

A clarifying numerical exercise. Plasma adrenaline rises from a basal ~0.1 nM to ~5 nM during stress — a 50-fold rise. The intracellular cascade amplifies this further.

• Receptor occupancy: with a typical β-adrenoceptor Kd ~10 nM, basal plasma adrenaline (~0.1 nM) occupies ~1% of receptors; stressed plasma adrenaline (~5 nM) occupies ~33%. The occupancy change is ~33-fold.
• G-protein activation: each occupied receptor catalyses GDP→GTP exchange on ~10 G-proteins per second over its ~30-second active lifetime — so each occupied receptor activates ~300 G-proteins.
• cAMP production: each Gαₛ-GTP activates one adenylyl cyclase for ~10 seconds; adenylyl cyclase converts ATP to cAMP at ~10⁴ molecules per second — so each Gαₛ generates ~10⁵ cAMP molecules during its active lifetime.
• PKA activation: cAMP binds PKA regulatory subunits at micromolar affinity; a typical hepatocyte holds ~10⁴ PKA molecules. The cAMP rise (from ~100 nM resting to ~10 μM stimulated) saturates the receptors.
• Substrate phosphorylation: each active PKA catalytic subunit phosphorylates ~100 substrate molecules per second over its ~minutes-long active lifetime — ~10⁴ phosphorylation events per PKA.

Multiplying: 300 G-proteins × 10⁵ cAMP per G-protein × 10⁴ phosphorylations per PKA = ~3 × 10¹² downstream events per receptor activation. The amplification is staggering. Note that this is a cellular amplification — every hepatocyte in the liver experiences the same cascade, and the response is summed across the tissue.

This calculation makes vivid why hormones operate at picomolar plasma concentrations and why receptor downregulation (after sustained stimulation, cells endocytose β-adrenoceptors, reducing surface density) is an essential safety mechanism. Without downregulation, sustained hormone exposure would drive runaway downstream cascades.

---

Hypothalamic–Pituitary Axis

Many endocrine systems are organised hierarchically as a three-tier cascade — hypothalamus → anterior pituitary → peripheral endocrine gland. This architecture provides integration with neural inputs, amplification at each tier, and negative feedback at multiple levels.

• Hypothalamus: secretes releasing hormones (CRH, TRH, GnRH, GHRH) and inhibiting hormones (somatostatin, dopamine) into the hypophyseal portal system — a short, high-concentration delivery route to the anterior pituitary.
• Anterior pituitary: in response to hypothalamic signals, secretes trophic hormones (ACTH, TSH, FSH, LH, GH, prolactin) into systemic circulation.
• Peripheral gland: trophic hormones drive secretion of effector hormones (cortisol from adrenal cortex, thyroxine from thyroid, sex steroids from gonads).

The architecture allows negative feedback at three levels: peripheral hormone inhibits its own trophic hormone at the pituitary; peripheral hormone inhibits the corresponding releasing hormone at the hypothalamus; trophic hormone inhibits releasing hormone (a "short-loop" feedback). The multi-level feedback gives stability and tight control.

Two important pituitary hormones (ADH and oxytocin) bypass this architecture: they are synthesised in hypothalamic neurones whose axons project directly into the posterior pituitary, where the hormones are stored in vesicles and released directly into systemic circulation. Posterior-pituitary hormones are therefore neurohormones — hormonal effectors of neural signals.

---

Worked Example — Glucagon vs Oestrogen Side-by-Side

Tracing a single contrast highlights the architectural divide.